Why some tumor-fighting T cells get stuck in nearby lymph nodes after cancer vaccines
Lymphoid residency of Tcf-1+ CD8+ T cells during tumor vaccine responses
This research looks at why a special group of tumor-fighting T cells remain trapped in tumor-draining lymph nodes after cancer vaccine responses, with the goal of helping people with advanced cancers get stronger, longer-lasting immune help.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11241981 on NIH RePORTER |
What this research studies
You’ll hear about a type of “stem-like” CD8 T cell that helps keep anti-cancer immunity going, and the team will study how these cells behave after tumor vaccines. They will track whether these cells become resident inside tumor-draining lymph nodes instead of traveling to tumors, using laboratory analyses and comparisons of cells from lymph nodes and tumors. The researchers will map the development and lineage relationships of these cells to understand why they lose their migratory ability. Findings could point to ways to change vaccine or combination treatments so more immune cells reach and attack tumors.
Who could benefit from this research
Good fit: People with advanced cancers—especially those receiving or eligible for tumor vaccines or other immunotherapies—would be the most relevant candidates for related clinical work.
Not a fit: People without cancer or those whose treatment plans do not involve vaccines or immune-based therapies are unlikely to see direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could help design vaccines or combination therapies that free and boost tumor-fighting T cells, improving durable responses to cancer immunotherapies.
How similar studies have performed: Prior studies have shown that 'stem-like' T cells are important for durable immunotherapy responses, but the idea that many become lymph-node resident after vaccine responses is a newer finding that has not yet been translated into proven patient treatments.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Zhang, Nu — University of Texas Hlth Science Center
- Study coordinator: Zhang, Nu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.